» Articles » PMID: 25300613

Capturing Patient-Reported Outcome (PRO) Data Electronically: The Past, Present, and Promise of EPRO Measurement in Clinical Trials

Overview
Journal Patient
Specialty Health Services
Date 2014 Oct 11
PMID 25300613
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Patient-reported outcomes (PROs) are an important means of evaluating the treatment benefit of new medical products. It is recognized that PRO measures should be used when assessing concepts best known by the patient or best measured from the patient's perspective. As a result, there is growing emphasis on well defined and reliable PRO measures. In addition, advances in technology have significantly increased electronic PRO (ePRO) data collection capabilities and options in clinical trials. The movement from paper-based to ePRO data capture has enhanced the integrity and accuracy of clinical trial data and is encouraged by regulators. A primary distinction in the types of ePRO platforms is between telephone-based interactive voice response systems and screen-based systems. Handheld touchscreen-based devices have become the mainstay for remote (i.e., off-site, unsupervised) PRO data collection in clinical trials. The conventional approach is to provide study subjects with a handheld device with a device-based proprietary software program. However, an emerging alternative for clinical trials is called bring your own device (BYOD). Leveraging study subjects' own Internet-enabled mobile devices for remote PRO data collection (via a downloadable app or a Web-based data collection portal) has become possible due to the widespread use of personal smartphones and tablets. However, there are a number of scientific and operational issues that must be addressed before BYOD can be routinely considered as a practical alternative to conventional ePRO data collection methods. Nevertheless, the future for ePRO data collection is bright and the promise of BYOD opens a new chapter in its evolution.

Citing Articles

Circadian rhythmicity of symptomatic phenotypes in multiple sclerosis: the CircaMS study protocol and feasibility of biomarker collection.

Taccardi D, Gowdy H, Li V, Wing A, Baharnoori M, Finlayson M BMJ Open. 2025; 15(3):e095357.

PMID: 40044201 PMC: 11883553. DOI: 10.1136/bmjopen-2024-095357.


Principles of good practice for translation of electronic clinical outcome assessments.

Shalhoub H, Turner M, Bradley-Gilbride A, Eremenco S, Muehlan H, Parks-Vernizzi E J Patient Rep Outcomes. 2025; 9(1):26.

PMID: 40036000 PMC: 11880485. DOI: 10.1186/s41687-025-00859-4.


Best practices and pragmatic approaches for patient-reported outcomes and quality of life measures in cancer clinical trials.

Bandos H, Torres-Saavedra P, Culakova E, Gunn H, Lee M, Duan F J Natl Cancer Inst Monogr. 2025; 2025(68):14-21.

PMID: 39989038 PMC: 11848031. DOI: 10.1093/jncimonographs/lgae047.


Measurement Equivalence and Feasibility of the Electronic and Paper Versions of the POSAS, EQ-5D, and DLQI: A Randomized Crossover Trial.

Meirte J, Hellemans N, Daele U, Maertens K, Denteneer L, Anthonissen M Eur Burn J. 2024; 5(4):321-334.

PMID: 39727906 PMC: 11727002. DOI: 10.3390/ebj5040030.


Data collection methods for patient-reported outcome measures in cancer randomised controlled trials: a protocol for a rapid scoping review.

Lehmann J, Krepper D, Pe M, Kulis D, Giesinger J, Sztankay M BMJ Open. 2024; 14(9):e084935.

PMID: 39260865 PMC: 11409248. DOI: 10.1136/bmjopen-2024-084935.


References
1.
Eremenco S, Coons S, Paty J, Coyne K, Bennett A, McEntegart D . PRO data collection in clinical trials using mixed modes: report of the ISPOR PRO mixed modes good research practices task force. Value Health. 2014; 17(5):501-16. DOI: 10.1016/j.jval.2014.06.005. View

2.
Coons S, Gwaltney C, Hays R, Lundy J, Sloan J, Revicki D . Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. Value Health. 2009; 12(4):419-29. DOI: 10.1111/j.1524-4733.2008.00470.x. View

3.
Bushnell D, Reilly M, Galani C, Martin M, Ricci J, Patrick D . Validation of electronic data capture of the Irritable Bowel Syndrome--Quality of Life Measure, the Work Productivity and Activity Impairment Questionnaire for Irritable Bowel Syndrome and the EuroQol. Value Health. 2006; 9(2):98-105. DOI: 10.1111/j.1524-4733.2006.00087.x. View

4.
Tiplady B . Electronic Patient Diaries and Questionnaires - ePRO Now Delivering on the Promise?. Patient. 2012; 3(3):179-83. DOI: 10.2165/11537600-000000000-00000. View

5.
Gwaltney C, Shields A, Shiffman S . Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic review. Value Health. 2008; 11(2):322-33. DOI: 10.1111/j.1524-4733.2007.00231.x. View